Jeffrey Spafford’s Post

With annual reverification season, or “blizzard season,” rapidly approaching, life sciences organizations should begin to assess their patient support program's past performance. In this Drug Channels article, Patient Solutions Division President Jan Nielsen details how life sciences organizations should evaluate how patient support program vendors adapt to a changing landscape through technology, talent off-ramps and specialty pharmaceutical expertise. Read more: https://loom.ly/gSygcTg #InformedAccess #ImprovedOutcomes

All specialty pharmaceutical stakeholders have seen patient support programs evolving alongside the industry’s growing adoption of technology. During a recent virtual roundtable hosted by McKinsey & Company, Business Development Vice President Jordan Armstrong discussed how current tech-first approaches can continue to drive patient access to therapy and improve outcomes in the future. #InformedAccess #ImprovedOutcomes

In the ever-evolving landscape of pharmaceutical research and development, a groundbreaking approach is taking center stage: the feedback loop. This innovative concept is transforming the way pharmaceutical companies interact with patients, healthcare providers, and regulatory bodies, creating a more efficient and effective drug development process. As we delve into this exciting new frontier, we’ll explore how the pharma feedback loop is reshaping the industry and paving the way for more personalized, patient-centric healthcare solutions. https://lnkd.in/exR7brXA

Excited to share insights from my recent pharmaceutical industrial visit! Explored cutting-edge facilities, learned about innovative processes, and gained a deeper understanding of the dynamic pharmaceutical industry. Grateful for the opportunity to witness firsthand the advancements shaping healthcare. #PharmaIndustry #IndustrialVisit

Are you ready for a game-changing transformation in the healthcare industry? The rise of biosimilars and generics is not only making healthcare more affordable but also driving competition and innovation in the pharmaceutical industry. Join me in exploring this exciting topic and learning more about how we can shape the future of healthcare together. As more biosimilars and generics enter the market, patients can expect to receive better healthcare outcomes and treatments. The market competition created by biosimilars and generics is pushing pharmaceutical companies to create better and more effective drugs to stay ahead of the game. Let's continue the conversation and work towards a better and more affordable healthcare system for all. Together, we can revolutionize the healthcare industry and ultimately benefit patients and healthcare systems worldwide. #biosimilars #generics #pharmaceuticals #marketcompetition

🚀 Tomorrow 🚀 Join Claudia Stemple, Michael Sullivan, George Moore, and Amanda Wilson for a thought-provoking discussion on Using Embedded Provider Workflows to Fast-Track Specialty Therapy Access at the Informa Connect Patient Support Services Congress. Panel description: The future of #patientservices is already here. Join industry leaders to explore the transformative impact of integrating core hub services directly into provider workflows. Learn how this streamlined approach accelerates key services like benefits verification and prior authorization approvals for patients. Gain insights on the real-world applications that have delivered measurable results for specialty pharmaceutical manufacturers. Learn more about the panel: https://lnkd.in/eB3ypF8p

In the ever-evolving pharmaceutical landscape, effective communication between biopharma companies and payers is essential. Cencora’s Alvana Maliqi, PharmD, MBA, Associate Director of Value and Access Strategy, is at the forefront of groundbreaking research on pre-approval information exchange (PIE) and on how biopharma manufacturers can utilize this information more efficiently. In an interview with Fierce Pharma, she shares how key strategies lead to successful product launches and payer communications: https://ow.ly/AfV350SBySi

In this comprehensive article, we’ll dive deep into the world of drug pricing strategy, exploring the various elements that shape how pharmaceutical companies determine the cost of their products. From research and development expenses to market dynamics and regulatory pressures, we’ll uncover the multifaceted nature of drug pricing and its impact on patients, healthcare systems, and the industry itself. https://lnkd.in/eckEGK9Z

𝐖𝐞𝐥𝐜𝐨𝐦𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐞𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐩𝐚𝐧𝐞𝐥 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 𝐨𝐧 "𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 𝐚𝐧𝐝 𝐁𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫𝐬: 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐅𝐮𝐭𝐮𝐫𝐞 𝐏𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐬." Our esteemed panelists, Barbara Hendrickson, Gillian Woollett, and Christopher Conway, will delve into regulatory strategies, market dynamics, and innovative trends shaping the biopharmaceutical landscape. Gain invaluable insights into the evolving world of #biopharmaceuticals and #biosimilars, and discover what the future holds for the pharmaceutical industry. 𝐉𝐨𝐢𝐧 𝐮𝐬 𝐢𝐧 𝐞𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐠𝐫𝐨𝐮𝐧𝐝𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐭𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐩𝐫𝐨𝐦𝐢𝐬𝐞 𝐭𝐨 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞. 👉 https://lnkd.in/gJdi4krZ 🔗 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐞-𝐛𝐨𝐨𝐤 𝐧𝐨𝐰: https://lnkd.in/gv7R4SPi #Biopharmaceuticals #Biosimilars #PharmaTrends #HealthcareInnovation #RegulatoryAffairs #MarketDynamics #PharmaceuticalIndustry #FutureOfPharma #PanelDiscussion #HealthcareRevolution #PharmaLeaders #InnovationInPharma #Biotech #PharmaFuture

"Expanding my pharmaceutical knowledge! Today, I completed the online course "Drug Development Process: Combating Pain" on OpenLearn. Key takeaways: - Understanding pain management and treatment options - Insights into pharmaceutical research and development - Clinical trial design and regulatory considerations - Innovative approaches to pain therapy This course enhanced my understanding of the drug development lifecycle, from discovery to market approval. #DrugDevelopment #PharmaceuticalScience #PainManagement #OnlineLearning #OpenLearn #ProfessionalDevelopment #PharmacyStudent #HealthcareInnovation"